PEPR PROPSY was delighted to support the participation of French researchers in the European College of Neuropsychopharmacology (ECNP) Roadmap Meeting, held on January 19 and 20 in Amsterdam, a scientific meeting dedicated to the validation of biomarkers for precision psychiatry.
As part of the ECNP Roadmap, which aims to redefine the diagnostic framework for mental disorders, this event highlighted the urgent need to move from conceptual frameworks to practical implementation.
Building on previous editions that explored scientific foundations and methodological approaches, this meeting focused on biomarker-based strategies aimed at revolutionizing psychiatric drug development and patient care.
At the heart of the discussions were:
✔️ the transition of biomarkers from research to clinical practice,
✔️ the design and optimization of clinical trials,
✔️ the development of personalized therapeutic strategies.
Discover the program here 👉 https://lnkd.in/dyvuNpVn
Thanks to the support of PEPR PROPSY program, Jan Berkehan Erkilic, MD MPH, Antoine Lefrere, Ariel Frajerman, Jasmina Mallet, and Anton Iftimovici took part in discussions bringing together researchers, clinicians, industry representatives, and regulatory authorities, alongside Marion Leboyer, Scientific Director of the program, and Marie-Hélène Soto, Program Manager.
This meeting also provided an opportunity to exchange ideas with European and international colleagues, paving the way for new scientific collaborations in precision psychiatry.